P3 Health Partners Inc <PIII.OQ> expected to post a loss of 11 cents a share - Earnings Preview
P3 Health Partners Inc PIII.OQ PIII.O is expected to show a rise in quarterly revenue when it reports results on March 27 for the period ending December 31 2024
The Chicago Illinois-based company is expected to report a 9.0% increase in revenue to $378.056 million from $346.86 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for P3 Health Partners Inc is for a loss of 11 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for P3 Health Partners Inc is $1.00, above its last closing price of $0.19.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.04 | -0.04 | -0.29 | Missed | -673.3 |
Jun. 30 2024 | -0.07 | -0.05 | -0.09 | Missed | -80 |
Mar. 31 2024 | -0.11 | -0.11 | -0.16 | Missed | -50 |
Dec. 31 2023 | -0.19 | -0.11 | -0.22 | Missed | -100 |
Sep. 30 2023 | -0.29 | -0.22 | -0.12 | Beat | 45.5 |
Jun. 30 2023 | -0.14 | -0.13 | -0.09 | Beat | 30.8 |
Mar. 31 2023 | -0.63 | -0.67 | -0.22 | Beat | 67.4 |
Dec. 31 2022 | -0.91 | -2.26 | Missed | -148.4 |
This summary was machine generated March 25 at 20:36 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recommended Articles
